Tenapanor May Improve Uncontrolled Hyperphosphatemia
By blocking paracellular phosphate transport, tenapanor added to phosphate binders may improve the hyperphosphatemia management in patients on maintenance dialysis, a study found.
Kidney Week 2019
In-Depth Focus From Kidney Week 2019: Hemodialysis-Dependent Chronic Kidney Disease
Complete Coverage
Adding Aliskiren to Losartan Ups Hyperkalemia Risk in CKD
Adding aliskiren to losartan in patients with nondiabetic chronic kidney disease does not result in a greater renal protection and increases their risk of hyperkalemia, a study found.
High Dialysate Calcium Is a Risk Factor for Hospitalization, Death
In a study, use of “high” dialysate calcium of 3.5 mEq/L in new hemodialysis patients was associated with poor outcomes.
Fine Particles in Air Up Hospitalization Risk Among Hemodialysis Patients
People with breathing and heart problems, children, and the elderly may be particularly sensitive to fine particulate matter in the air.
Heart Disease More Common in HD Patients Who Live at Low Altitudes
The proportion of hemodialysis patients with congestive heart failure was 21% for those living below 1000 feet vs 19% and 13% for those living at 1000 to 4000 feet and above 4000 feet, respectively, a study found.
Survival Odds Better for Women vs Men on Hemodialysis
In the hemodialysis population, women have a 48% decreased risk of death compared with men in adjusted analyses, a study found.
Body Mass Index Modifies Dialysis Adequacy and Mortality
Patients with low BMI had higher mortality risk even at higher spKt/V compared with patients with normal BMI and target range spKt/V of 1.2 to less than 1.4.
Low Protein Excretion Is a Risk Factor for Mortality in Hemodialysis
In a study of new dialysis patients, low proteinuria was associated with nearly triple the risk for early mortality compared with relatively normal proteinuria.
Stopping ACE Inhibitors, ARBs After Hyperkalemia Episode Ups Death Risk in CKD
Patients with CKD who discontinued ACE inhibitors or angiotensin receptor blockers after a hyperkalemia episode had a 2.6-fold increased risk of all-cause mortality compared with patients who continued taking the drugs.
Roxadustat Superior to Epoetin Alfa in New Dialysis Patients
Newly released safety data also show that roxadustat is associated with reduced cardiovascular risks compared with epoetin alfa.
Metabolic Acidosis in CKD Underdiagnosed, Undertreated
In a study, approximately one-fifth of CKD patients with metabolic acidosis received a diagnostic code for it.
Hyperkalemia Ups CKD Progression Risk
Hyperkalemia in patients with chronic kidney disease (CKD) stage 3 or 4 more than doubles their risk of progressing to CKD stage 5, a study found.
Gout Ups Risks of Kidney Transplant Complications, Return to HD
Gout that develops in kidney transplant recipients increases their risk of worse outcomes, according to 2 new studies.
Frail Hemodialysis Patients Tend to Worsen Over Time
In a study, two-thirds of hemodialysis patients met criteria for frailty, which impairs independence, cognition, mood, and quality of life.
Magnesium-Containing Antacids May Increase Fracture Risk
Kidney disease patients who took magnesium-containing antacids were 15% more likely to experience hip fracture than nonusers of antacids.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Kidney Week 2019 HDD/CKD In-Depth
Loading... 
Loading...